Your browser doesn't support javascript.
loading
Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study.
Harada, Yasuhiko; Nagata, Yasunobu; Kihara, Rika; Ishikawa, Yuichi; Asou, Norio; Ohtake, Shigeki; Miyawaki, Shuichi; Sakura, Toru; Ozawa, Yukiyasu; Usui, Noriko; Kanamori, Heiwa; Ito, Yoshikazu; Imai, Kiyotoshi; Suehiro, Youko; Kobayashi, Shinichi; Kitamura, Kunio; Sakaida, Emiko; Onizuka, Makoto; Takeshita, Akihiro; Ishida, Fumihiro; Suzushima, Hitoshi; Ishizawa, Kenichi; Naoe, Tomoki; Matsumura, Itaru; Miyazaki, Yasushi; Ogawa, Seishi; Kiyoi, Hitoshi.
Afiliação
  • Harada Y; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Nagata Y; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Japan; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Kihara R; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Ishikawa Y; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Asou N; Department of Hematology, International Medical Center, Saitama Medical University, Hidaka, Japan.
  • Ohtake S; Kanazawa University, Kanazawa, Japan.
  • Miyawaki S; Division of Hematology, Tokyo Metropolitan Ohtsuka Hospital, Tokyo, Japan.
  • Sakura T; Leukemia Research Center, Saiseikai Maebashi Hospital, Maebashi, Japan.
  • Ozawa Y; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
  • Usui N; Division of Clinical Oncology and Hematology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
  • Kanamori H; Department of Hematology, Kanagawa Cancer Center, Kanagawa, Japan.
  • Ito Y; Department of Hematology, Tokyo Medical University, Tokyo, Japan.
  • Imai K; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
  • Suehiro Y; Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Kobayashi S; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Saitama, Japan.
  • Kitamura K; Division of Hematology, Ichinomiya Municipal Hospital, Ichinomiya, Japan.
  • Sakaida E; Department of Hematology, Chiba University Hospital, Chiba, Japan.
  • Onizuka M; Department of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan.
  • Takeshita A; Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Ishida F; Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
  • Suzushima H; Department of Hematology, Kumamoto Shinto General Hospital, Kumamoto, Japan.
  • Ishizawa K; Division of Hematology and Cell Therapy, Third Department of Internal Medicine, Yamagata University Faculty of Medicine, Yamagata, Japan.
  • Naoe T; National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Matsumura I; Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University, Osaka, Japan.
  • Miyazaki Y; Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Ogawa S; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Japan.
  • Kiyoi H; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Electronic address: kiyoi@med.nagoya-u.ac.jp.
Leuk Res ; 66: 20-27, 2018 03.
Article em En | MEDLINE | ID: mdl-29360622
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Nucleares / Leucemia Mieloide Aguda / Proteínas Estimuladoras de Ligação a CCAAT / Inibidores de Proteínas Quinases / Tirosina Quinase 3 Semelhante a fms Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Nucleares / Leucemia Mieloide Aguda / Proteínas Estimuladoras de Ligação a CCAAT / Inibidores de Proteínas Quinases / Tirosina Quinase 3 Semelhante a fms Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2018 Tipo de documento: Article